What is the ICD-10 (International Classification of Diseases, 10th Revision) code for Congestive Heart Failure (CHF) screening?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICD-10 Codes for Congestive Heart Failure (CHF) Screening

The ICD-10 code for CHF screening is Z13.6 (Encounter for screening for cardiovascular disorders). This code should be used when a patient is being evaluated for potential heart failure without previously established diagnosis.

Primary ICD-10 Codes for CHF Screening

  • Z13.6: Encounter for screening for cardiovascular disorders - This is the primary code for CHF screening encounters 1
  • Z13.89: Encounter for screening for other disorder - Can be used as a secondary code when screening for multiple conditions including CHF 1

ICD-10 Codes for Established CHF Diagnosis

When CHF is already diagnosed, the following codes should be used instead of screening codes:

  • I50.1: Left ventricular failure, unspecified 2
  • I50.2: Systolic heart failure (90% PPV for EF ≤50%) 2
    • I50.20: Unspecified systolic heart failure
    • I50.21: Acute systolic heart failure
    • I50.22: Chronic systolic heart failure
    • I50.23: Acute on chronic systolic heart failure
  • I50.3: Diastolic heart failure (92% PPV for EF >50%) 2
    • I50.30: Unspecified diastolic heart failure
    • I50.31: Acute diastolic heart failure
    • I50.32: Chronic diastolic heart failure
    • I50.33: Acute on chronic diastolic heart failure
  • I50.4: Combined systolic and diastolic heart failure 2
  • I50.9: Heart failure, unspecified 2

Important Considerations for Coding Accuracy

  • The principal diagnosis code (first position) has a 98% positive predictive value for acute heart failure hospitalization, while first/second position has only 66% PPV 2
  • Reliance solely on ICD codes can result in missing approximately one-third of patients with clinical evidence of acute CHF 3
  • When coding for CHF screening, document the reason for screening (e.g., risk factors, symptoms) 4
  • For accurate coding, specify the type of heart failure when diagnosed (systolic vs. diastolic) 2

Diagnostic Criteria Supporting CHF Screening

When documenting CHF screening, include the following elements to support medical necessity:

  • Assessment of patient's ability to perform routine activities of daily living 1
  • Evaluation of volume status, orthostatic blood pressure changes, weight, height, and BMI calculation 1
  • Initial laboratory tests including CBC, urinalysis, electrolytes, BUN, creatinine, glucose, lipid profile, liver function tests, and TSH 1
  • 12-lead ECG and chest radiograph (PA and lateral) 1
  • Consideration of echocardiography with Doppler to assess LVEF, LV size, wall thickness, and valve function 1

Common Pitfalls in CHF Coding

  • Using unspecified codes (I50.9) when more specific codes are applicable based on clinical documentation 2
  • Failing to document the ejection fraction, which is critical for proper classification 2
  • Relying solely on ICD codes for identifying CHF cases can lead to underestimation of the true prevalence by approximately 25% 3
  • Not updating codes when a patient transitions from screening to diagnosis 4

Best Practices for CHF Screening Documentation

  • Document all risk factors that justify the screening 5
  • Include results of natriuretic peptide measurements (BNP or NT-proBNP) when available 1, 5
  • Record specific symptoms that prompted screening (dyspnea, fatigue, edema) 5
  • Document objective findings from physical examination and diagnostic tests 1
  • Specify the plan for further evaluation if screening suggests possible CHF 5

Remember that proper documentation and coding are essential not only for reimbursement but also for accurate epidemiological tracking of CHF prevalence and outcomes.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.